Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 945 of 1,261

  1. US 8063047

    Pyridazine compounds and methods

    Northwestern University · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  2. US 8062654

    Drug releasing biodegradable fiber for delivery of therapeutics

    The Board of Regents of the University of Texas System · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  3. US 8057810

    Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  4. US 8057807

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  5. US 8058257

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  6. US 8058063

    Method of producing region-specific neurons from human neuronal stem cells

    The Board of Regents of the University of Texas System · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  7. US 8058403

    Antibodies to stromal cell-derived factor-1 polypeptides

    Five Prime Therapeutics, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  8. US 8058268

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  9. US 8058226

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  10. US 8058446

    Certain substituted amides, method of making, and method of use thereof

    GILEAD CONNECTICUT, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  11. US 8058237

    Stable composition of GDF-5 and method of storage

    Advanced Technologies and Regenerative Medicine, LLC · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  12. US 8057990

    Screening method

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  13. US 8058025

    Methods for determining efficacy of chemotherapeutic agents

    Precision Therapeutics, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  14. US 8058244

    Cyclic peptide antitumor agents

    Northwestern University · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  15. US 8058248

    Foot and mouth disease virus vaccine comprising interferons

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  16. US 8058300

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  17. US 8058280

    Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  18. US 8058249

    Immunostimulatory nucleic acid molecules

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  19. US 8058271

    Selective inhibitors of rock protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  20. US 8058295

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  21. US 8058385

    Method for preparing conjugates using polymer maleimides

    Nektar Therapeutics · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  22. US 8053412

    NELL-1 peptides

    The Regents of the University of California · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  23. US 8053487

    Multifunctional acrylates used as cross-linkers in dental and biomedical self-etching bonding adhesives

    United States of America as represented by the Secretary of the Air Force · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  24. US 8053443

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.